The global antibodies contract manufacturing market generated US$ 4.8 billion in revenue in 2022, and it is anticipated that this market will grow at a CAGR of 12.5% to reach a valuation of US$ 17.5 billion by the end of 2033. Persistence Market Research estimates that by 2033, the market for monoclonal antibodies will be worth roughly US$15.9 billion. In the global biopharmaceutical contract manufacturing industry, which was estimated to be worth roughly US$ 15.7 Bn in 2022, antibody contract manufacturing sales represent approximately 30.5% of total revenue.
Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/32933
From 2016 to 2022, the global market experienced a historic CAGR of 9.6%.
Medications created using biotechnology are collectively referred to as biologics or biopharmaceutical drugs. Biologics are complex entities like proteins or cells that are used as medicinal ingredients, as opposed to small-molecule drugs. Protein therapies were a niche market in the 20th century, but they have significantly changed since the advent of antibody medicines in the 21st. When protein treatments eventually surpassed the sales of new pharmaceuticals, the pharmaceutical industry underwent a paradigm shift.
Get up to 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/32933
Companies
-
- AMRI
- AGC Biologics
- Aldevron
- Eurofins CDMO
- Boehringer Ingelheim BioXcellence
- FUJIFILM Diosynth Biotechnologies
- Emergent BioSolutions
- KBI Biopharma
- Lonza
- Novasep
- Nitto Avecia Pharma Services
- Pierre Fabre
- Samsung BioLogics
- Synthon
- Thermo Fisher Scientific
- AbbVie, Inc.
Competition Landscape
The Antibodies Contract Manufacturing Market will continue to consolidate as major competitors pursue inorganic growth strategies to provide customers with comprehensive solutions. Furthermore, chances for contract manufacturing of antibodies with significant capabilities are growing as a result of scientific developments in biopharmaceuticals.
Differentiation strategies for long-term sustainability are being driven by the growing antibody contract manufacturing business strategy, innovation in the biopharmaceutical industry, disruptive drug discovery and manufacturing technologies, and significant growth potential in the production of high potency biopharmaceuticals.
Request For Customization @ https://www.persistencemarketresearch.com/request-customization/32933
Key Segments Covered in Antibody Contract Manufacturing Industry Research
Product:
-
- Monoclonal Antibodies
- Antibody Fragments
- Polyclonal Antibodies
Expression System:
Mammalian
Microbial
-
- Bacteria
- Yeast
Company Size:
-
- Small
- Mid-sized
- Large
- Very large
Scale of Operation:
-
- Preclinical
- Clinical
- Commercial
Region:
-
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Why is the U.S. Antibody Contract Manufacturing Market Booming?
“Rising Number of Clinical Trials and Increasing Demand for Contract Manufacturing”
The U.S. accounted for around 89.4% market share in the North America market in 2022. The growing number of clinical trials, the existence of major market participants, the advanced healthcare system, the rise in demand for antibodies contract manufacturing, and the increased focus of governments on biologics are all contributing factors.
Additionally, a number of mAb candidates for the treatment of COVID-19, had reached human clinical trials, and were made more widely available to patients through fast-track approval or emergency use authorization in a matter of months. The market in the nation has expanded as a result of these activities.
About Us
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact Us
Persistence market research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com